View, browse and sort the list of CPhI North America Conference sessions and show floor programming by pass type, track, and format. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.
Joseph Zeleznik is currently Manager, Technical and Regulatory Affairs at MEGGLE USA, Inc. In this role, he is responsible for providing formulation and product application guidance as well as having quality and regulatory oversight for MEGGLE USA's North American lactose manufacture. Mr. Zeleznik received his B.S. and M.A. degrees in Chemistry from the State University of New York, College at New Paltz with a focus on instrumental analysis. Prior to joining MEGGLE USA, Mr. Zeleznik was Associate Director, R&D with JRS PHARMA and Research Manager with Penwest Pharmaceuticals Co. Mr. Zeleznik has over 20 years experience in the pharmaceutical industry, having specialized in the development and application of high functionality excipients, and in particular, co-processing applications for the performance enhancement of excipients and pharmacologically active ingredients. Currently a member of IPEC-Americas' Executive Committee, he also serves as Chairman of IPEC-Americas' Quality by Design/Excipient Composition (QbD/EC) committee and has assisted in the development of several IPEC Guides including the newly introduced Co-processed Excipients Guide. Mr. Zeleznik has authored or co-authored multiple articles published across various industry journals. He was a contributing author to the Handbook of Pharmaceutical Excipients, 8th Ed. published in 2017 and participated in the development of the NF co-processed excipient monograph, Silicified Microcrystalline Cellulose. Mr. Zeleznik is an avid outdoorsman, enjoying camping, hiking, biking, and wildlife photography and has been an active as a cub scout and boy scout leader with Boy Scouts of America for many years.